Journey Medical (DERM) EBT (2020 - 2026)

Journey Medical's EBT history runs 7 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

• Quarterly EBT rose 45.25% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.5 million (down 15.6% YoY) and the FY2025 annual result came in at -$11.4 million, up 22.18% from the prior year.
• EBT was -$2.2 million for Q1 2026 at Journey Medical, down from -$1.2 million in the prior quarter.
• Across five years, EBT topped out at $16.9 million in Q3 2023 and bottomed at -$10.6 million in Q4 2022.
• A 5-year average of -$3.6 million and a median of -$3.4 million in 2024 frame the typical range for EBT.
• Peak annual rise in EBT reached 267.67% in 2023, while the deepest fall reached 695.6% in 2023.
• Journey Medical's EBT stood at -$10.6 million in 2022, then surged by 81.02% to -$2.0 million in 2023, then jumped by 178.43% to $1.6 million in 2024, then sank by 178.82% to -$1.2 million in 2025, then sank by 78.83% to -$2.2 million in 2026.
• Business Quant data shows DERM's EBT at -$2.2 million in Q1 2026, -$1.2 million in Q4 2025, and -$2.3 million in Q3 2025.